PAION Deutschland GmbH   Report issue

For profit Phase 2
Founded: Aachen Germany (2000)
Status: Left NME R&D (2016)

Organization Overview

First Clinical Trial
2001
NCT00638781
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2006

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 2 Trials (2)

Desmoteplase (2 trials)

enecadin (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Stroke (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 3
  • # of Trial APIs: 2